filmov
tv
Novel therapies in AML and MDS
Показать описание
Thomas Cluzeau, MD, PhD, of the Central University Hospital of Nice, Nice, France, discusses novel targeted therapies for high-risk acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) presented at EHA 2020. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
0:02:54
0:18:23
0:28:29
0:02:25
0:52:20
0:09:29
0:03:40
0:02:33
0:01:01
0:05:01
0:05:17
0:02:24
0:18:29
0:01:34
0:02:14
0:16:58
0:57:36
0:16:41
0:02:20
0:17:57
0:01:32
0:03:44
0:59:42
0:03:29